# Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)

> **NCT04918069** · PHASE2 · COMPLETED · sponsor: **Christian Medical College, Vellore, India** · enrollment: 160 (actual)

## Conditions studied

- Chemotherapy-induced Nausea and Vomiting

## Interventions

- **DRUG:** Capsaicin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04918069
- **Lead sponsor:** Christian Medical College, Vellore, India
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-18
- **Primary completion:** 2022-05-14
- **Final completion:** 2022-05-14
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2022-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04918069

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04918069, "Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04918069. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*